METTL3 and posterior cortical atrophy: METTL3 expression has been found to be upregulated in PCa patients and PCa cell lines compared with non-malignant prostate cells, with METTL3 implicated in PCa progression, poorer prognosis and treatment resistance [[64], [68], [71], [72], [73]].